Alpha-Melanocyte-Stimulating Hormone (α-MSH) | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Alpha-Melanocyte-Stimulating Hormone (α-MSH)

Also known as: α-MSH, alpha-MSH, Alpha-melanotropin, Melanotropin, α-melanocortin

Neuropeptide / Melanocortin peptide (tridecapeptide derived from pro-opiomelanocortin [POMC])

Research chemicalLast updated: October 19, 2026Based on 21 peer-reviewed studies

What it is

Researchers study Alpha-Melanocyte-Stimulating Hormone (α-MSH) for its role in inflammation, appetite regulation, skin pigmentation, and cartilage protection. It activates receptors that help regulate the immune response and energy balance throughout the body. No FDA-approved therapeutic use; evidence comes primarily from animal and cell studies.

The scientific side

α-MSH is a 13 amino acid neuropeptide derived by intracellular cleavage of pro-opiomelanocortin (POMC). It acts at melanocortin receptors (MCRs), a family of G-protein-coupled receptors; the melanocortin-1 receptor (MC1-R) is primarily involved in regulation of skin pigmentation and is expressed on melanocytes and melanoma cells. The MC4 receptor has been most closely linked to body weight regulation, where α-MSH acts as an anorexigenic signal after central injection. Activation of POMC neurons increases α-MSH production, inhibiting orexigenic signals. α-MSH also has potent anti-inflammatory activity, modulates immune cell function including macrophage activity, and participates in regulation of sympathetic nervous system activity. In the ocular microenvironment, α-MSH (together with NPY) suppresses phagosome maturation in macrophages and promotes immune privilege.

Class: Neuropeptide / Melanocortin peptide (tridecapeptide derived from pro-opiomelanocortin [POMC])

Administration & storage

Administration
Subcutaneous injection of α-MSH analogues (Melanotan-I/II) reported by survey respondents (PMID: 30142729)Intracranial/intrahypothalamic injection into medial preoptic area in animal studies (PMID: 2671829)In vitro perifusion of neurointermediate lobe tissue (PMID: 21554663)In vitro perifusion of rat hypothalamic slices (PMID: 1698247)
Storage
No abstracts in the reviewed literature describe storage conditions for α-MSH.
Cautions
Development of multiple new atypical naevi reported within one week of subcutaneous injection of a Melanotan (α-MSH analogue), raising concern for risk of stimulating dysplastic naevi or malignant melanoma.,Melanotan-I and Melanotan-II are α-MSH analogues purchased and injected illicitly without regulatory oversight; purity and safety of unregulated internet-sourced substances are unknown.,No human pharmacokinetic or safety data for α-MSH itself (as distinct from synthetic analogues) are available in the reviewed literature.,Sterile technique is essential for any injectable peptide to prevent contamination and infection.,No approved dosing, reconstitution, or administration protocol for α-MSH has been described in the reviewed literature.

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification

WADA

Not stated in reviewed literature — requires manual verification

Health Canada

Not stated in reviewed literature — requires manual verification